An open, non-controlled, parallel, ascending multiple-dose, multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of SOBI003 in pediatric MPS IIIA patients An open, non-controlled, parallel, ascending multiple-dose, multicenter study to assess the safety, ...
An open, non-controlled, parallel, ascending multiple-dose, multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of SOBI003 in pediatric MPS IIIA patients An open, non-controlled, parallel, ascending multiple-dose, multicenter study to assess the safety, ...
Mucopolysaccharidosis Type IIIA or Sanfilippo Syndrome MedDRA version: 20.1;Level: LLT;Classification code 10028094;Term: Mucopolysaccharidosis IH;System Organ Class: 100000004850;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] Mucopolysaccharidosis Type IIIA or Sanfilippo Syndrome MedDRA version: 20.1;Level: LLT;Classificatio ...
Product Name: Chemicallymodifiedrecombinanthumansulfamidase Product Code: SOBI003 INN or Proposed INN: not applicable Other descriptive name: CHEMICALLYMODIFIEDRECOMBINANTHUMANSULFAMIDASEProduct Name: Chemicallymodifiedrecombinanthumansulfamidase Product Code: SOBI003 INN or Proposed ...
An open, non-controlled, parallel, ascending multiple-dose, multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of SOBI003 in pediatric MPS IIIA patients An open, non-controlled, parallel, ascending multiple-dose, multicenter study to assess the safety, ...
An open, non-controlled, parallel, ascending multiple-dose, multicenter study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of SOBI003 in pediatric MPS IIIA patients An open, non-controlled, parallel, ascending multiple-dose, multicenter study to assess the safety, ...
Mucopolysaccharidosis Type IIIA or Sanfilippo Syndrome MedDRA version: 20.1;Level: LLT;Classification code 10028094;Term: Mucopolysaccharidosis IH;System Organ Class: 100000004850;Therapeutic area: Diseases [C] - Congenital, Hereditary, and Neonatal Diseases and Abnormalities [C16] Mucopolysaccharidosis Type IIIA or Sanfilippo Syndrome MedDRA version: 20.1;Level: LLT;Classificatio ...
Product Name: Chemicallymodifiedrecombinanthumansulfamidase Product Code: SOBI003 Other descriptive name: CHEMICALLYMODIFIEDRECOMBINANTHUMANSULFAMIDASEProduct Name: Chemicallymodifiedrecombinanthumansulfamidase Product Code: SOBI003 Other descriptiv ...